Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: MedPacto, Inc.

Market Cap 123B 81.37M 70.19M 64.54M 60.74M 114M 7.68B 115M 765M 298M 3.77B 305M 299M 13.04B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 84.25B 55.63M 47.99M 44.12M 41.53M 78.04M 5.25B 78.7M 523M 204M 2.58B 209M 204M 8.91B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day+3.90%
1 week+7.47%
Current month+1.84%
1 month-16.88%
3 months-32.68%
6 months-43.47%
Current year-46.18%
1 week 3,175
Extreme 3175
3,660
1 month 3,105
Extreme 3105
4,375
Current year 3,105
Extreme 3105
7,980
1 year 3,105
Extreme 3105
8,650
3 years 2,750
Extreme 2750
22,000
5 years 2,750
Extreme 2750
75,300
10 years 2,750
Extreme 2750
134,200
Manager TitleAgeSince
Chief Executive Officer 72 19/06/2013
President 66 28/03/2024
Comptroller/Controller/Auditor 70 28/03/2022
Director TitleAgeSince
Director/Board Member 72 19/06/2013
Director/Board Member 66 28/03/2024
Director/Board Member 63 28/03/2024
Date Insider Type Main position Quantity % Market Cap.
04/03/25Buy 10,000 0.0292%
04/03/25Buy

Chairperson

15,000 0.0438%
04/03/25Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
+3.90%+7.47%-4.77%-82.33% 78.6M
+3.23%+2.25%+65.02%+116.66% 54.54B
+0.04%+5.05%+43.44%+36.75% 43.86B
+3.11%+7.54%-11.74%-15.73% 22.63B
+2.40%+6.78%-2.17%+385.43% 20.7B
-0.53%-0.27%+12.68%-37.07% 15.84B
+5.27%+1.87%+13.67%-38.00% 14.83B
+1.35%+0.65%+27.97%+179.41% 13.1B
-5.17%+4.13%+13.12% - 12.66B
-0.51%+5.74%+78.25%+103.03% 11.56B
Average +1.32%+0.70%+23.55%+72.02% 20.98B
Weighted average by Cap. +1.50%+0.18%+33.27%+91.21%

Financials

2024 2025
Net sales - 3.9K 2.57 2.22 2.04 1.92 3.61 242.95 3.64 24.2 9.42 119.24 9.66 9.46 412.49
Net income -20.14B -13.3M -11.47M -10.55M -9.93M -18.66M -1.26B -18.81M -125M -48.67M -616M -49.92M -48.85M -2.13B -12.81B -8.46M -7.3M -6.71M -6.32M -11.87M -798M -11.97M -79.51M -30.96M -392M -31.75M -31.07M -1.36B
Net Debt -53.54B -35.35M -30.5M -28.04M -26.39M -49.59M -3.34B -50.01M -332M -129M -1.64B -133M -130M -5.66B -38.97B -25.74M -22.2M -20.41M -19.21M -36.1M -2.43B -36.41M -242M -94.18M -1.19B -96.59M -94.53M -4.12B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
17/06/26 3,595.00 +3.90% 81,611
16/06/26 3,460.00 0.00% 98,863
15/06/26 3,460.00 +1.32% 68,715
12/06/26 3,415.00 +0.15% 70,720
11/06/26 3,410.00 +2.40% 61,021
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!